课题基金 / 基金详情

Dihydropyridines for the prevention of dementia among patients with hypertension

Dihydropyridines for the prevention of dementia among patients with hypertension
二氢吡啶用于预防高血压患者痴呆
批准号：
478990
负责人：
Renoux Christel
金额：
$15.33万
依托单位：
Lady Davis Institute for Medical Research (Mtl)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2023
资助国家：
加拿大
项目状态：
未结题
起止时间：
2023-03-01 至 2025-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=478990&lang=en
关键词：
Cohort Study Dementia Dihydropyridines Electronic Medical Records Pharmacoepidemiology

项目摘要

项目成果

Renoux Christel的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Patients with hypertension have an increased risk of dementia. However, reducing blood pressure with antihypertensive drugs has not been consistently associated with a reduced risk of dementia. Some antihypertensive drugs named dihydropyridines are of par
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Use of Incretin-Based Drugs and SGLT-2 Inhibitors for the Prevention of Parkinson's Disease Among Patients with Type 2 Diabetes
Gabapentinoids and the risk of severe respiratory events in patients with chronic obstructive pulmonary disease.
Gabapentinoids and the risk of severe respiratory events in patients with chronic obstructive pulmonary disease
INSPEIR: International Study for the Prevention of Dementia with Incretin-based drugs
海外基金